Inventor
BENNETT FRANK
US54 patents
⚠️ This page may combine multiple inventors who share the name “BENNETT FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
29 patentsUS6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US6403564B1Jun 11, 2002
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP122 citations97
US6277830B1Aug 21, 2001
5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
SCHERING CORP120 citations97
US5661151AAug 26, 1997
Tetrahydrofuran antifungals
SCHERING CORP69 citations96
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US7592316B2Sep 22, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP34 citations93
US5714490AFeb 3, 1998
Tetrahydrofuran antifungals
SCHERING CORP37 citations93
US5693626ADec 2, 1997
Tetrahydrofuran antifungals
SCHERING CORP24 citations93
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US7425576B2Sep 16, 2008
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP20 citations91
US5516784AMay 14, 1996
Anti-HIV (AIDS) agents
SCHERING CORP26 citations90
US7423058B2Sep 9, 2008
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP15 citations83
US5710154AJan 20, 1998
Tetrahydrofuran antifungals
SCHERING CORP13 citations74
US5703236ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP11 citations74
US5703079ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP16 citations74
US7115578B2Oct 3, 2006
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP8 citations73
US6924270B2Aug 2, 2005
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP11 citations71
US7619094B2Nov 17, 2009
Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
SCHERING CORP5 citations62
US6673775B2Jan 6, 2004
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP4 citations62
US6043245AMar 28, 2000
Tetrahydrofuran antifungal phosphate
SCHERING CORP3 citations62
US5693815ADec 2, 1997
Peptides
SCHERING CORP5 citations61
US7718691B2May 18, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations51
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US5795874AAug 18, 1998
Water soluble antibiotics
SCHERING CORP0 citations51
US5652226AJul 29, 1997
Water soluble antibiotics
SCHERING CORP1 citations51
US7759499B2Jul 20, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations49
MERCK SHARP & DOHME
6 patentsUS10544130B2Jan 28, 2020
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME1 citations73
US10221163B2Mar 5, 2019
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME4 citations73
US9732111B2Aug 15, 2017
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME2 citations71
US10227331B2Mar 12, 2019
Metallo-β-lactamase inhibitors
MERCK SHARP & DOHME1 citations62
US11685761B2Jun 27, 2023
Cyclic di-nucleotide compounds as sting agonists
MERCK SHARP & DOHME0 citations51
US9765107B2Sep 19, 2017
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME1 citations51
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
GIRIJAVALLABHAN VINAY
3 patentsUS9061041B2Jun 23, 2015
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY49 citations93
US9156872B2Oct 13, 2015
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY45 citations92
US9150603B2Oct 6, 2015
2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
GIRIJAVALLABHAN VINAY14 citations82
BENNETT FRANK
2 patentsARASAPPAN ASHOK
2 patentsWALMART APOLLO LLC
2 patentsKWONG CECIL D
1 patentSAKSENA ANIL K
1 patentSTEINBERG DAVID A
1 patentShowing the top 50 of 54 patents by PatentIndex Score.